Anteris Technologies (AVR) Proxy filing summary

Executive summary

• Special Meeting of Stockholders postponed from September 11, 2025, to September 18, 2025, to allow more time for shareholder participation.

• The record date for voting remains August 11, 2025.

• The meeting will be held virtually via live webcast.

• The company is focused on developing and commercializing innovative medical devices for structural heart disease.

• Forward-looking statements caution about uncertainties regarding quorum and stockholder approval at the Special Meeting.

Voting matters and shareholder proposals

• Board unanimously recommends voting FOR the proposals outlined in the definitive Proxy Statement filed August 18, 2025.

• Voting instructions are provided for both Common Stock and CHESS Depositary Interests (CDIs) holders.

• Prior votes remain valid unless changed by the shareholder.

Board of directors and corporate governance

• The Board is actively facilitating broader shareholder participation by postponing the Special Meeting.